ALYSSA YOUNG: Open Payments
NPI 1285228510 · CLAYTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 35 payments from 11 companies in 2025. Trend: 2023 $827 · 2024 $660 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $238 |
| ABBVIE INC. | 6 | $111 |
| Lilly USA, LLC | 4 | $78 |
| UCB, Inc. | 3 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Wegovy, MOUNJARO, Bimzelx, VRAYLAR, VOQUEZNA, Ozempic, RINVOQ, BENLYSTA.
Industry payments across NC — which companies pay providers there.
